Oguz, F. S. Et Al. 2006. HLA-A*11, -B*15, -DRB1*08 and homozygosity for HLA-B-DRB1 are associated with risk in multiple myeloma. 20th European Immunogenetics and Histocompatibility Conference , (Oslo, Norway), 533-534.

Oguz, F. S., Kalayoglu, S., Erer, B., Kekik, C., Ozturk, G., Carin, M., ... Dorak, M. T.(2006). HLA-A*11, -B*15, -DRB1*08 and homozygosity for HLA-B-DRB1 are associated with risk in multiple myeloma . 20th European Immunogenetics and Histocompatibility Conference (pp.533-534). Oslo, Norway

Oguz, F. Et Al. "HLA-A*11, -B*15, -DRB1*08 and homozygosity for HLA-B-DRB1 are associated with risk in multiple myeloma," 20th European Immunogenetics and Histocompatibility Conference, Oslo, Norway, 2006

Oguz, F. S. Et Al. "HLA-A*11, -B*15, -DRB1*08 and homozygosity for HLA-B-DRB1 are associated with risk in multiple myeloma." 20th European Immunogenetics and Histocompatibility Conference , Oslo, Norway, pp.533-534, 2006

Oguz, F. S. Et Al. (2006) . "HLA-A*11, -B*15, -DRB1*08 and homozygosity for HLA-B-DRB1 are associated with risk in multiple myeloma." 20th European Immunogenetics and Histocompatibility Conference , Oslo, Norway, pp.533-534.

@conferencepaper{conferencepaper, author={F. S. Oguz Et Al. }, title={HLA-A*11, -B*15, -DRB1*08 and homozygosity for HLA-B-DRB1 are associated with risk in multiple myeloma}, congress name={20th European Immunogenetics and Histocompatibility Conference}, city={Oslo}, country={Norway}, year={2006}, pages={533-534} }